Summary
Harmaline (10 mg/kg i.p. 45 min) increased acetylcholine (ACh) levels in the rat striatum but did not affect the ACh content of the parietal cortex, the hippocampus or certain limbic nuclei. This change in striatal ACh levels may reflect a decreased utilization of the transmitter. The selective effect of harmaline on striatal cholinergic neurones is probably mediated by interneuronal processes. Various hypotheses were examined:
-
1.
The harmaline-induced increase in striatal ACh levels was not abolished after destruction of the nigrostriatal dopaminergic neurones. Harmaline (10−5 M or 10−4 M) and its metabolites (harmalol, harmine) also failed to modify the activity of the striatal dopamine-sensitive adenylate cyclase. This excludes any involvement of dopaminergic mechanisms in the action of harmaline on striatal cholinergic neurones.
-
2.
The harmaline-induced increase in striatal ACh levels could not be prevented by diazepam (5 mg/kg i.p. 65 min). In contrast the increase in ACh content elicited by picrotoxin (25 mg/kg i.p. 60 min) was abolished by diazepam. Furthermore, the harmaline-and picrotoxin-induced rises in striatal ACh levels were additive. These results suggest that GABA mechanisms are not involved in the effect of harmaline on striatal cholinergic neurones.
-
3.
Parachlorophenylalanine pretreatment (48 and 24 h, 300 mg/kg i.p.) which reduced striatal serotonin (5-HT) levels by 95%, failed to affect ACh levels in the striatum. The inhibitor of 5-HT synthesis did not prevent the harmaline-induced rise in ACh levels. Harmaline (10−5 M or 10−4 M), harmine and harmalol, did not stimulate the 5-HT sensitive adenylate cyclase in the colliculi of newborn rats. It is thus unlikely that harmaline reduces the activity of striatal cholinergic neurones by its effects on 5-HT transmission. Moreover, other monoamine oxidase inhibitors (pargyline and tranylcypromine) were also ineffective on cholinergic neurones.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agid, Y., Javoy, F., Glowinski, J., Bouvet, D., Sotelo, C.: Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity. Brain Res. 58, 291–301 (1973)
Agid, Y., Guyenet, P., Glowinski, J., Beaujouan, J. C., Javoy, F.: Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat. Brain Res. 86, 488–492 (1975a)
Agid, Y., Javoy, F., Guyenet, P., Beaujouan, J. C., Glowinski, J.: Effect of surgical and pharmacological manipulations of the dopaminergic nigro neostriatal neurons on the activity of the neostriatal cholinergic system in the rat. In: Neuropsycho-pharmacology, Proc. IX. Congress CINP (J. R. Boissier, H. Hippius, and D. Pichot, eds.), pp. 480–485. Amsterdam: Excerpta Medica 1975b
Bak, I. J., Kurokawa, M., Hassler, R., Kim, J. S.: Effects of harmaline on striatal serotonin and acetylcholine, pp. 77–88. In: Second International Meeting of the International Society for Neurochemistry (Tamburini, ed.), Milano 1969
Barbeau, A.: The pathogenesis of Parkinson's diseases: A new hypothesis. Canad. med. Ass. J. 87, 802–807 (1962)
Bartholini, G., Stadler, H., Lloyd, K. G.: The effect of striatal neurotransmitters. In: Neuropsychopharmacology, Proc. IX. Congress CINP (J. R. Boissier, H. Hippius and D. Pichot, eds.), pp. 487–492. Amsterdam: Excerpta Medica 1975
Bockaert, J., Premont, J., Glowinski, J., Thierry, A. M., Tassin, J. P.: Topographical distribution of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase-interaction of d-LSD with dopaminergic receptors. Brain Res. 107, 303–315 (1976)
Boireau, A., Ternaux, J. P., Bourgoin, S., Hery, F., Glowinski, J., Hamon, M.: The determination of picogram levels of 5-HT in biological fluids. J. Neurochem. 26, 201–204 (1976)
Bourgoin, S., Enjalbert, A., Adrien, J., Hery, F., Hamon, M.: Midbrain raphe lesion in the newborn rat: II. Biochemical alterations in serotoninergic innervations. Brain Res. (in press, 1976)
Cheramy, A., Bioulac, B., Besson, M. J., Vincent, D., Glowinski, J., Gauchy, C.: Radioenzymatic estimation of catecholamines released from the caudate nucleus in the cat and in the monkey. In: Neuropsychopharmacology, Proc. IX. Congress CINP (J. R. Boissier, H. Hippius, and P. Pichot, eds.), pp. 493–498. Amsterdam: Excerpta Medica 1975
Consolo, S., Ladinsky, H., Garattini, S.: Effect of several dopaminergic drugs and trihexylphenidyl on cholinergic parameters in the rat striatum. J. Pharm. Pharmacol. 26, 275–277 (1974)
Consolo, S., Ladinsky, H., Bianchi, S.: Decrease in rat striatal acetylcholine levels by some direct and indirect acting dopaminergic antagonists. Europ. J. Pharmacol. 33, 345–351 (1975)
Costa, E., Guidotti, A., Mao, C. C., Suria, A.: New concepts on the mechanism of action of benzodiazepines. Life Sci. 17, 167–186 (1975)
Domino, E. F., Wilson, A. E.: Psychotropic drugs influences on brain acetylcholine utilization. Psychopharmacologia (Berl.) 25, 291–298 (1972)
Euvrard, C., Javoy, F., Herbet, A., Glowinski, J.: Effect of quipazine, a serotonin like drug on striatal cholinergic interneurones. Europ. J. Pharmacol. (in press, 1976)
Guyenet, P. G., Agid, Y., Javoy, F., Beaujouan, J. C., Rossier, J., Glowinski, J.: Effects of dopaminergic receptor agonists and antagonists on the activity of the neostriatal cholinergic system. Brain Res. 84, 227–244 (1975)
Guyenet, P. G., Javoy, F., Euvrard, C., Glowinski, J.: The effect of drugs on choline and acetylcholine content in the rat striatum following two methods of sacrifice. Neuropharmacology (in press, 1976)
Haefely, W., Kulcsar, A., Mohler, H., Pieri, L., Polc, P., Schaffner, R.: Possible involvement of GABA in the central actions of benzodiazepines. In: Mechanism of action of benzodiazepines (A. Costa and P. Greengard, eds.), pp. 131–151, New York: Raven Press 1975
Haefely, W., Polc, F., Keller, H. H., Schaffner, R., Möhler, H., Kulczar, A., Pieri, L.: Interaction of minor tranquilizers with synaptic processes mediated by GABA. Abstr. Collegium Intern. Neuro-psychopharmacologicum, 10th Meeting Quebec (Canada), July 4–9, p. 47 (1976)
Hamon, M., Bourgoin, S., Enjalbert, A., Bockaert, J., Hery, F., Ternaux, J. P., Glowinski, J.: The effects of quipazine on 5-HT metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 294, 99–108 (1976)
Javoy, F., Agid, Y., Bouvet, D., Glowinski, J.: Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum. J. Pharmacol. exp. Ther. 182, 454–463 (1972)
Javoy, F., Euvrard, C., Bockaert, J., Glowinski, J.: Effects of gabaergic and serotoninergic drugs on the activity of cholinergic neurons in rat striatum. Proc. 10th CINP Congress, Quebec July 1976. Oxford: Pergamon Press (in press, 1976a)
Javoy, F., Herbet, A., Euvrard, C., Glowinski, J.: Involvement of the dopamine nigrostriatal system in the picrotoxin effect on striatal acetylcholine levels. Brain Res. (in press, 1977)
Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine sensitive adenylate cyclase in caudate nucleus of rat brain and its similarity of the “dopamine receptor”. Proc. nat. Acad. Sci. (Wash.) 69, 2145–2149 (1972)
Kim, J. S., Hassler, P., Kurokawa, M., Bak, I. J.: Abnormal movements and rigidity induced by harmaline in relation to striatal acetylcholine, serotonin and dopamine. Exp. Neurol. 29, 189–200 (1970)
Ladinsky, H., Consolo, S., Bianchi, S., Jori, A.: Increase in striatal acetylcholine by picrotoxin in the rat: evidence for a gabaergic dopaminergic-cholinergic link. Brain Res. 108, 351–361 (1976)
Laverty, R., Taylor, K. M.: The fluorometric assay of catecholamines and related compounds. Improvements and extensions to the hydroxy-indole technique. Analyt. Biochem. 22, 269–278 (1968)
Lorens, S. A., Guldberg, H. C.: Regional 5-hydroxytryptamine following selective midbrain raphe lesions in the rat. Brain Res. 78, 45–56 (1974)
McGeer, P. L., Grewaal, D. S., McGeer, E. G.: Influence of noncholinergic drugs on rat striatal ACh levels. Brain Res. 80, 211–217 (1974)
Malick, J. B., Doren, E., Barnett, A.: Quipazine-induced headtwitch produced by serotonin receptor activation in mice. Fed. Proc. 34, 3289 (1975)
Mao, C. C., Guidotti, A., Costa, E.: Inhibition by diazepam of the tremor and the increase of cerebellar c-GMP content elicited by harmaline. Brain Res. 83, 516–519 (1975)
Pepeu, G.: The release of ACh from the brain: an approach to the study of the central cholinergic mechanisms. In: Progress in neurobiology, Vol. 2, part 3 (G. A. Korkut and J. W. Phillis, eds.), pp. 257–288. Oxford: Pergamon Press 1973
Poirier, L. J., Singh, P., Boucher, R.: Opposite effect of harmaline on serotonin and on dopamine and its metabolites homovanillic acid and norepinephrine, in the brain of the cat. Canad. J. Physiol. Pharmacol. 46, 585–589 (1968)
Poirier, L., Filion, M., Langelier, P., Larochelle, P.: Brain nervous mechanisms involved in the so-called extrapyramidal motor and psychomotor disturbances. In: Progress in neurobiology, Vol. 5, Part 1. pp. 1–56. Oxford: Pergamon Press 1975
Rodriquez, R., Rojas-Raminez, J. A., Drucker-Colin, R. R.: Serotonin-like actions of quipazine on the central nervous system. Europ. J. Pharmacol. 24, 164–171 (1973)
Rossier, J., Bauman, A., Benda, P.: Improved purification of rat brain choline acetyltransferase by using an immuno absorbant. FEBS Letters 32, 231–234 (1973)
Saavedra, J. P., Braunstein, M., Axelrod, J.: A specific and sensitive enzymatic isotopic microassay for serotonin in tissues. J. Pharmacol. exp. Ther. 186, 505–515 (1973)
Sethy, V. H., Von Woert, M. H.: Regulation of striatal ACh concentration by dopamine receptors. Nature (Lond.) 251, 528–530 (1974)
Singh, P., Poirier, L. J., Boucher, R.: The effect of monoamine oxidase inhibitors on the concentration of dopamine and serotonin in the striatum of the cat with and without unilateral brain stem lesions. Canad. J. Physiol. Pharmacol. 45, 897–904 (1967)
Stadler, H., Lloyd, K. G., Gadea-Ciria, M., Bartholini, G.: Enhanced striatal release by chlorpromazine and its reversal by apomorphine. Brain Res. 55, 476–480 (1973)
Steg, G.: Striatal cell activity during systemic administration of monoaminergic and cholinergic drugs, pp. 26–29. In: Third Symposium on Parkinson's Disease (F. J. Gillingham and I. M. L. Donaldson, eds.) Edinburgh: Livingstone 1969
Szerb, J. C., Malik, H., Hunter, E. G.: Relationship between acetylcholine content and release in the cat's cerebral cortex. Canad. J. Physiol. Pharmacol. 48, 780–790 (1970)
Trabucchi, M., Cheney, D. L., Racagni, G., Costa, E.: Involvement of brain cholinergic mechanisms in the action of chlorpromazine. Nature (Lond.) 249, 664–666 (1974)
Trabucchi, M., Cheney, D. L., Racagni, G., Costa, E.: In vivo inhibition of striatal ACh turnover by l-DOPA, apomorphine and (+)amphetamine. Brain Res. 85, 130–134 (1975)
Truex, R. C., Carpentier, M. B.: Human neuroanatomy, 6. ed., pp. 498–517. Baltimore: Williams and Wilkins Company 1973
Udenfriend, S., Witkop, B., Redfield, B. G., Weissback, H.: Studies with reversible inhibitors of monoamine oxidase: harmaline and related compounds. Biochem Pharmacol. 1, 160–165 (1958)
Von Hungen, K., Roberts, S., Hill, D. F.: Serotonin sensitive adenylate cyclase activity in immature rat brain. Brain Res. 84, 257–267 (1975)
Author information
Authors and Affiliations
Additional information
A preliminary report of these results was given at Collegium Internationale Neuropharmacologium X. Congress Quebec (Canada) July 4–9, 1976
Rights and permissions
About this article
Cite this article
Javoy, F., Euvrard, C., Herbet, A. et al. Lack of involvement of dopaminergic and GABA neurones in the inhibitory effect of harmaline on the activity of striatal cholinergic neurones in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 297, 233–239 (1977). https://doi.org/10.1007/BF00509266
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00509266